• Home

  • Health & Medicine

  • Urine sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated...
1

Urine sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

Embed Size (px)

Citation preview

Page 1: Urine sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

Cardiovascular Franchise: Multiple Approaches to ...€¦ · Targeting PCSK9 for Lipid Management PCSK9 mRNA Reduction Correlates with LDL-C Lowering in Preclinical Studies PCSK9

Cardiovascular Franchise: Multiple Approaches to ...€¦ · Targeting PCSK9 for Lipid Management PCSK9 mRNA Reduction Correlates with LDL-C Lowering in Preclinical Studies PCSK9

Documents
PCSK9-Inhibitor Treatment for Hypercholesterolemia

PCSK9-Inhibitor Treatment for Hypercholesterolemia

Documents
Preparing for a Novel Era in CV Prevention: Where do PCSK9 ... · CV Prevention: Where do PCSK9 Inhibitors Fit in Lipid Management Prof. John J.P. Kastelein, MD PhD FESC ... PCSK9

Preparing for a Novel Era in CV Prevention: Where do PCSK9 ... · CV Prevention: Where do PCSK9 Inhibitors Fit in Lipid Management Prof. John J.P. Kastelein, MD PhD FESC ... PCSK9

Documents
The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion Camilla Gustafsen, Mads Kjolby, Mette Nyegaard, Manuel Mattheisen, Jesper Lundhede,

The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion Camilla Gustafsen, Mads Kjolby, Mette Nyegaard, Manuel Mattheisen, Jesper Lundhede,

Documents
RNAi Therapeutics Targeting PCSK9 for LDLc … Therapeutics Targeting PCSK9 for LDLc Lowering in Hypercholesterolemia M. D. Frank-Kamenetsky1, T. Racie1, A. Akinc1, N. Anderson2, L

RNAi Therapeutics Targeting PCSK9 for LDLc … Therapeutics Targeting PCSK9 for LDLc Lowering in Hypercholesterolemia M. D. Frank-Kamenetsky1, T. Racie1, A. Akinc1, N. Anderson2, L

Documents
Alfalfa & hypercholesterolemia

Alfalfa & hypercholesterolemia

Health & Medicine
NOVA ABORDAGEM TERAPÊUTICA PARA DISLIPIDEMIAS: PCSK9€¦ · 4.6 PRÓ-PROTEÍNA CONVERTASE SUBTILISINA KEXINA TIPO 9 - PCSK9 40 4.6.1 Mecanismo de ação da PCSK9 42 4.6.2 Mutações

NOVA ABORDAGEM TERAPÊUTICA PARA DISLIPIDEMIAS: PCSK9€¦ · 4.6 PRÓ-PROTEÍNA CONVERTASE SUBTILISINA KEXINA TIPO 9 - PCSK9 40 4.6.1 Mecanismo de ação da PCSK9 42 4.6.2 Mutações

Documents
The Severe Hypercholesterolemia Phenotype · hypercholesterolemia are the same no matter the cause, the focus should be on the identification of subjects with severe hypercholesterolemia,

The Severe Hypercholesterolemia Phenotype · hypercholesterolemia are the same no matter the cause, the focus should be on the identification of subjects with severe hypercholesterolemia,

Documents
Hypercholesterolemia Case Presentation

Hypercholesterolemia Case Presentation

Documents
Urine-sample-derived human induced pluripotent stem cells as a … · urine-sample-derived human induced pluripotent stem cells (UhiPSCs) as an appropriate tool to model PCSK9-mediated

Urine-sample-derived human induced pluripotent stem cells as a … · urine-sample-derived human induced pluripotent stem cells (UhiPSCs) as an appropriate tool to model PCSK9-mediated

Documents
2012/11 - IR - PCSK9

2012/11 - IR - PCSK9

Documents
Familial Hypercholesterolemia Honors Genetics 2006

Familial Hypercholesterolemia Honors Genetics 2006

Documents
Inibidores da PCSK9 no tratamento de doenças ... · PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review Inibidores da PCSK9 no tratamento de doenças

Inibidores da PCSK9 no tratamento de doenças ... · PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review Inibidores da PCSK9 no tratamento de doenças

Documents
PCSK9 Inhibitors

PCSK9 Inhibitors

Documents
Update on PCSK9 Inhibitors

Update on PCSK9 Inhibitors

Documents
Novel Therapeutic Target of PCSK9

Novel Therapeutic Target of PCSK9

Documents
PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

Documents
Pcsk9 inhibitory

Pcsk9 inhibitory

Health & Medicine
Management of Dyslipidaemias: PCSK9 Inhibitionstatic.livemedia.gr/hcs2/.../al11531_us41_20141104120510_06_cata… · PCSK9 inhibitors in development Compound Company Phase of clinical

Management of Dyslipidaemias: PCSK9 Inhibitionstatic.livemedia.gr/hcs2/.../al11531_us41_20141104120510_06_cata… · PCSK9 inhibitors in development Compound Company Phase of clinical

Documents
IDENTIFICATION OF INHIBITORS FOR PCSK9

IDENTIFICATION OF INHIBITORS FOR PCSK9

Science
Human Pluripotent Stem Cell Functional Identification Kit · 2018-05-23 · Pluripotent stem cells encompass both embryonic and induced pluripotent stem cells, which are non-pluripotent

Human Pluripotent Stem Cell Functional Identification Kit · 2018-05-23 · Pluripotent stem cells encompass both embryonic and induced pluripotent stem cells, which are non-pluripotent

Documents
Naturally Occurring PCSK9 Inhibitors - unimi.it

Naturally Occurring PCSK9 Inhibitors - unimi.it

Documents
Objectives: “Hypercholesterolemia: Pathophysiology …courses.ahc.umn.edu/pharmacy/5822/Lectures/6122_Lipids_A_01.06.06.pdfObjectives: “Hypercholesterolemia: Pathophysiology and

Objectives: “Hypercholesterolemia: Pathophysiology …courses.ahc.umn.edu/pharmacy/5822/Lectures/6122_Lipids_A_01.06.06.pdfObjectives: “Hypercholesterolemia: Pathophysiology and

Documents
PCSK9 Inhibition : From Genetics to Patients · PCSK9 mutations and impact on LDL-C\爀屲 PCSK9 mutations represent the major source of variability in PCSK9 expression. Two type\൳

PCSK9 Inhibition : From Genetics to Patients · PCSK9 mutations and impact on LDL-C\爀屲 PCSK9 mutations represent the major source of variability in PCSK9 expression. Two type\൳

Documents
Familial Hypercholesterolemia

Familial Hypercholesterolemia

Documents
Hypercholesterolemia - Komunikasi Kesihatan

Hypercholesterolemia - Komunikasi Kesihatan

Health & Medicine
Hypercholesterolemia Increases Endothelial Superoxide ... · Numerous disease processes, including hypercholesterolemia ( 1), atherosclerosis(2),ischemiaandreperfusion(3),acuteor

Hypercholesterolemia Increases Endothelial Superoxide ... · Numerous disease processes, including hypercholesterolemia ( 1), atherosclerosis(2),ischemiaandreperfusion(3),acuteor

Documents
Further cardiovascular OUtcomes Research with PCSK9 ...clinicaltrialresults.org/Slides/ACC2017/Fourier_Sabatine.pdf · Further cardiovascular OUtcomes Research with PCSK9 Inhibition

Further cardiovascular OUtcomes Research with PCSK9 ...clinicaltrialresults.org/Slides/ACC2017/Fourier_Sabatine.pdf · Further cardiovascular OUtcomes Research with PCSK9 Inhibition

Documents
Induced pluripotent stem (iPS) cells Patient-Specific Pluripotent Stem Cells

Induced pluripotent stem (iPS) cells Patient-Specific Pluripotent Stem Cells

Documents
PCSK9 mutations in hypercholesterolemia - bioRxiv...2019/08/22  · PCSK9 mutations in hypercholesterolemia 1 A transient amphipathic helix in PCSK9’s prodomain facilitates low-density

PCSK9 mutations in hypercholesterolemia - bioRxiv...2019/08/22  · PCSK9 mutations in hypercholesterolemia 1 A transient amphipathic helix in PCSK9’s prodomain facilitates low-density

Documents